COMMUNIQUÉS West-GlobeNewswire

CONVOCATION A UNE ASSEMBLEE GENERALE EXTRAORDINAIRE D’IBA SA
10/06/2026
- - LUNDI 29 JUIN 2026 A 11H00 - - Cher Actionnaire, Le quorum requis pour la délibération et le vote sur les sujets à l'ordre du jour de l’assemblée générale extraordinaire des actionnaires de la Société qui était [...]
Urteste S.A. enrolls the first patient in the Panuri test clinical study
10/06/2026
Urteste S.A. enrolls the first patient in the Panuri test clinical study Gdańsk, Poland – 10 June 2026 – Urteste S.A. (Warsaw Stock Exchange: URT), a company developing innovative technology for the detection of cancer [...]
MAIA Biotechnology Activates and Opens Enrollment at Second U.S. Clinical Site for International Phase 2 THIO-101 Expansion Trial
10/06/2026
Additional data from MAIA’s THIO-101 expansion may further support an accelerated approval filing with the FDA Potential breakthrough therapy holds substantial commercial opportunity in a projected $70 billion global [...]
Nexalin Technology Reports Compelling Clinical Trial Results in Brazil to Support Product Launch. Trial Demonstrates 77.8% Anxiety Response Rate and Durable Benefits Across Depression, Insomnia and Quality of Life as Company Advances Brazilian Sales Plan.
10/06/2026
Study using Nexalin’s proprietary DIFS ™ 15 mA 77.5 Hz treatment platform demonstrated rapid, large-magnitude improvements in anxiety and depression with benefits maintained at 8-week follow-up Results further validate [...]
Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial
10/06/2026
The shipment of naturally derived psilocybin, comprising both biomass and 5mg capsules, supports a planned Phase 2 clinical trial in the United Kingdom and was completed under export authorization from Health Canada and [...]
Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Global Scientific and Clinical Recognition of Platform Technology
10/06/2026
Access the segment here THE WOODLANDS, TX, June 10, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve- [...]
Vivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to Cardiovascular Patients
10/06/2026
LITTLETON, Colo., June 10, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treatment of breathing- [...]
Physician Pay and Productivity Are Moving in Opposite Directions, MGMA Report Finds
10/06/2026
New benchmarks show compensation rising across all specialties in 2025 even as patient visits fell in all 23 core specialties and standard productivity measures declined in most — a disconnect driven by a worsening [...]
Data Published in Interventional Pain Medicine Indicates Participants Who Received SPRINT PNS as Prescribed Were Three Times More Likely to Achieve Meaningful Pain Relief
10/06/2026
CLEVELAND, June 10, 2026 (GLOBE NEWSWIRE) -- SPR ® announced the publication of “Observations from the RESET Clinical Trial: A Post-Hoc Per Protocol Analysis of Clinical Outcomes with Percutaneous 60-Day Medial Branch [...]
OneMedNet Executes on Growth Strategy: Secures Over $3 Million in New Bookings, Surpassing Full-Year 2025
10/06/2026
Strong Commercial Momentum Fueled by Demand for Regulatory-Grade Multi-Modal Real-World Data MINNEAPOLIS, June 10, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or [...]
Cosmos Health CEO Issues Letter to Shareholders: Building an Innovative AI-Driven Global Healthcare Platform — Record Growth with U.S. Expansion Underway
10/06/2026
Key Highlights Record revenue, continued momentum: all-time high $65.3M in FY2025; strongest-ever Q1 2026, carrying into Q2. Record operational momentum: CosmoFarm wholesale distribution and GMP-certified Cana contract [...]
JenaValve Appoints Matt Bacso as Chief Financial Officer
10/06/2026
IRVINE, Calif., June 10, 2026 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy® Transcatheter Heart Valve (THV) System, today announced the appointment of Matt Bacso, as Chief [...]
Earth Science Tech, Inc. (ETST) Annual Shareholder Letter for FY Ended March 31, 2026
10/06/2026
“We measure our progress not only by the milestones we reached, but by the capabilities we built to reach the ones still ahead.” Over 6.9 million shares of common stock repurchased since fiscal Q1 2026 Peaks Curative [...]
Prenetics Announces Record Q1 2026 Results with IM8 Revenue Reaching a Record ~$16.7 Million in May, Implying ~$200 Million in Annualized Recurring Revenue
10/06/2026
Q1 2026 revenue of $36.0 million with IM8 revenue of $33.8 million , up 23.1% from IM8 revenue of $27.4 million in Q4 2025 and nearly 6x year-over-year from IM8 revenue of $5.7 million in Q1 2025 Raises full-year 2026 [...]
Koi Peptides Launches Research Peptide Wholesale Program for Labs, Resellers, and Biotech R&D
10/06/2026
Cheyenne, WY, June 10, 2026 (GLOBE NEWSWIRE) -- Koi Peptides (Koi Research Labs LLC) has launched a research peptide wholesale program that supplies bulk, research-use-only peptides, with tiered pricing and per-batch [...]
Medecision Named #1 Care Management, LTSS, and Complex Care Coordination Technology Vendor by Black Book Research in 2026
10/06/2026
Annual State of Payer Digital Technology report recognizes client ratings of payer IT vendors KING OF PRUSSIA, Pa., June 10, 2026 (GLOBE NEWSWIRE) -- Medecision, a healthcare technology company whose unified data [...]
Pioneering evidence shows how entrepreneurship model can reduce extreme poverty among refugees
10/06/2026
New studies show DREAMS program boosts incomes, savings, and resilience in refugee communities across East Africa The IKEA Foundation has committed $7.4m to fund the next stage of DREAMS in Ethiopia while the Conrad N. [...]
Cullinan Therapeutics Shares New Clinical Data Across Its Portfolio of T Cell Engager Programs Targeting CD19 and BCMA in Autoimmune Diseases
10/06/2026
CLN-978 (CD19 TCE) EULAR data demonstrated potential for immune reset, including remissions, in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) CLN-978 data from the first RA multi-dose regimen [...]
Harrow Re-Launches VERKAZIA® (cyclosporine ophthalmic emulsion) 0.1% for Vernal Keratoconjunctivitis, Addressing Significant Unmet Need in Pediatric Eyecare
10/06/2026
VERKAZIA is now supported by a comprehensive commercial strategy focused on physician education, patient access, and affordability initiatives to ensure dependable supply and remove access barriers VERKAZIA is indicated [...]

Pages